42nd Annual J.P. Morgan Healthcare Conference - Bayer

42nd Annual J.P. Morgan Healthcare Conference Stefan Oelrich Member of the Board of Management of Bayer AG President Pharmaceuticals January 9, 2024 Bayer Pharma’s Strategic Agenda RENEW TOPLINE REALLOCATE RESOURCES REBUILD PIPELINE Drive continued sales momentum and ensure blockbuster potential of Nubeqa and Kerendia ................
................